TB Alliance welcomes the European Commissions proposed pharmaceutical package, especially with regards to: 1) addressing unmet medical needs, 2) proposing incentives to tackle antimicrobial resistance, 3) regulatory support, and 4) reporting on publicly funded financial support.
GAT
Global Alliance for Tuberculosis Drug Development (TB Alliance)
NGO · United States · EU Transparency Register 636752920377-18
3
positions filed
in the 583 files tracked
3
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 964 non-governmental organisations on this site, they rank #349 by legislative files engaged — a count of participation, not a measure of influence.
0.8
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2016
in the register since
Declares membership of
- DSW - https://www.dsw.org/en/eu/
- AMR Stakeholder Network - https://epha.org/amr-stakeholder-network/
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Non-governmental organisations
- Registered as
- The Global Alliance for TB Drug Development (TB Alliance)
- Head office
- New York, United states
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Global in PolicySpeak: request access →
Work at Global Alliance for Tuberculosis Drug Development (TB Alliance)? so we know who speaks for it.
Their record over time
Global Alliance for Tuberculosis Drug Development (TB Alliance) filed 3 positions between 2 Feb 2021 and 8 Nov 2023, across 3 of the 583 legislative files tracked here, attaching a full position paper 1 time.
2021 · 2 filed2023 · 1 filed
What they argued
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster acting, and affordable tuberculosis (TB) drugs. It is part of a group of Product Development Partnerships (PDPs), which aim to address existing market failures by linking the public, private, and philanthropic sectors.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster acting, and affordable tuberculosis (TB) drugs. It is part of a group of Product Development Partnerships (PDPs), which aim to address existing market failures by linking the public, private, and philanthropic sectors.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Global Alliance for Tuberculosis Drug Development (TB Alliance) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 26.
Is this your organization?
Everything on this page comes from Global Alliance for Tuberculosis Drug Development (TB Alliance)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.